Remimazolam is a benzodiazepine-type sedative that was developed using molecular-level techniques. A recent study showed the drug to have a faster onset, more predictable effects and shorter recovery time for patients than other drugs used during colonoscopy.
A study on the drug was published in the most recent issue of Anesthesia & Analgesia.
More Articles on Gastroenterology:
Eliminating Dietary Gluten May Decrease Chance of Developing Type 1 Diabetes
5 Key Trends in GI/Endoscopy
The Latest in GI Cancer: Q&A With Dr. Neville Bamji of New York Gastroenterology Associates
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
